Evidence map›Paper›PMID 39976031›Full record

ArticleCurrent pharmaceutical biotechnology2026

Jamil A Shilpi, Dipto Kumer Sarker, Veronique Seidel, Mohammad Tuhin Ali, Shaikh Jamal Uddin, Ananya Basak, Shaown Chakraborty, M Khairuzzaman, Akhlak Un Nahar, Fayad Bin Abdus Salam

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jamil A ShilpiPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.ORCID 0000-0001-8938-9240
Dipto Kumer SarkerPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.ORCID 0000-0002-6033-9669
Veronique SeidelNatural Products Research Laboratory, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.ORCID 0000-0003-3880-5261
Mohammad Tuhin AliDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, 1000, Bangladesh.ORCID 0000-0002-0889-6548
Shaikh Jamal UddinPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.ORCID 0000-0003-3163-2118
Ananya BasakPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.
Shaown ChakrabortyPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.
M KhairuzzamanPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.ORCID 0000-0001-8269-3450
Akhlak Un NaharPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.
Fayad Bin Abdus SalamPharmacy Discipline, Life Science School, Khulna University, Khulna, 9208, Bangladesh.ORCID 0000-0002-1928-7676

Funding

Khulna University Research and Innovation Centre, Khulna, Bangladesh KU/RC-04/2000-281
6 · The paper itself

Abstract

backgroundAntibiofilm agents serve as an essential tool in the fight against antibiotic resistance, and natural products provide a promising source for potential drug leads.

objectiveThis study investigates the activity of twenty Bangladeshi medicinal plants against

methodsThe plant extracts were tested by microtiter plate-based assay against S. aureus and P. aeruginosa biofilms. Molecular docking and molecular dynamics simulation (MD) were conducted using PyRx and GROMACS, respectively.

resultsThe best activity was identified for

conclusionEpicatechin and its derivative EEE could be used as scaffolds for the development of new antibiofilm agents against

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiofilmsBiological ProductsPlant ExtractsPseudomonas aeruginosaStaphylococcus aureusTrans-ActivatorsMicrobial Sensitivity TestsMolecular Docking SimulationMolecular Dynamics SimulationAnti-Bacterial AgentsBacterial ProteinsBiological ProductsLasR protein, Pseudomonas aeruginosaPlant ExtractsTrans-ActivatorsAntibiofilmCassia fistulaepicatechinnatural productsPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID39976031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.